Influenza H1N1 vaccine

Marea Patounas*, Treasure McGuire

*Corresponding author for this work

Research output: Contribution to journalLetterResearchpeer-review

13 Downloads (Pure)

Abstract

[Extract]
Editor, – We wish to comment on the New drugs section of Australian Prescriber in relation to H1N1 swine flu vaccine (Aust Prescr 2009;32:165-71). Even before launch, Australian consumers were asking for information on the vaccine. Readers may be interested in the depth and variety of questions asked of pharmacists operating Medicines Line (funded by National Prescribing Service - NPS).This national consumer telephone hotline provides information about prescription, over-the-counter and complementary medicines. Most (82%) of the 85 questions received between August and October 2009 related to vaccine safety. A representative sample of the questions is shown below.
Original languageEnglish
Pages (from-to)5
Number of pages1
JournalAustralian Prescriber
Volume33
Issue number1
DOIs
Publication statusPublished - Feb 2010

Fingerprint Dive into the research topics of 'Influenza H1N1 vaccine'. Together they form a unique fingerprint.

Cite this